Literature DB >> 2282716

Neurofibromatosis 2: a clinically and genetically heterogeneous disease? Report on 10 sporadic cases.

L Mayfrank1, B Wullich, G Wolff, J Finke, E Gouzoulis, J M Gilsbach.   

Abstract

Clinical and genetic data of 10 patients with neurofibromatosis 2 (NF-2) are presented. Interestingly, no family history of neurofibromatosis was detectable in any of them, which indicates that these are sporadic cases of NF-2, most likely due to a new mutational event. According to our own results and the data in the literature, sporadic cases of NF-2 are clinically characterized by a high incidence of multiple meningiomas and spinal tumors in addition to the bilateral occurrence of acoustic neurinomas. The clinical heterogeneity of NF-2 is pointed out and the possible existence of different forms of this disease is discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2282716     DOI: 10.1111/j.1399-0004.1990.tb03596.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  3 in total

1.  Type II neurofibromatosis presenting as quadriceps atrophy.

Authors:  L Grazzi; L Chiapparini; E A Parati; S Giombini; D D'Amico; M Leone; G Bussone
Journal:  Ital J Neurol Sci       Date:  1998-04

Review 2.  Clinical and genetic patterns of neurofibromatosis 1 and 2.

Authors:  N K Ragge
Journal:  Br J Ophthalmol       Date:  1993-10       Impact factor: 4.638

3.  Neurofibromatosis type 2 appears to be a genetically homogeneous disease.

Authors:  S A Narod; D M Parry; J Parboosingh; G M Lenoir; M Ruttledge; G Fischer; R Eldridge; R L Martuza; M Frontali; J Haines
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.